These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5681513)

  • 21. The ability of maternal antibody to increase the immune response in infants.
    Levi MI; Kravtzov FE; Levova TM; Fomenko GA
    Immunology; 1969 Feb; 16(2):145-8. PubMed ID: 5769975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of pertussis antibody in the infant and effect on vaccine response.
    Van Savage J; Decker MD; Edwards KM; Sell SH; Karzon DT
    J Infect Dis; 1990 Mar; 161(3):487-92. PubMed ID: 2313127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histamine-sensitising factor of Bordetella pertussis differentiated from immunogens by neutralisation and passive protection tests.
    Preston NW; Garrity P
    J Pathol Bacteriol; 1967 Apr; 93(2):483-92. PubMed ID: 4293307
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of orally administered Bordetella pertussis vaccine in mice.
    Hof H; Finger H; Körner L; Milcke L
    Dev Biol Stand; 1976; 33():47-53. PubMed ID: 182602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness.
    Hirsch MS; Nahmias AJ; Murphy FA; Kramer JH
    J Exp Med; 1968 Jul; 128(1):121-32. PubMed ID: 5662010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J
    Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract]   [Full Text] [Related]  

  • 28. Protective serum antibodies in Tyzzer's disease of mice.
    Fujiwara K; Takahashi R; Kurashina H; Matsunuma N
    Jpn J Exp Med; 1969 Oct; 39(5):491-504. PubMed ID: 4191244
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants.
    Leuridan E; Hens N; Peeters N; de Witte L; Van der Meeren O; Van Damme P
    Pediatr Infect Dis J; 2011 Jul; 30(7):608-10. PubMed ID: 21206396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immune response suppressed by specific antibody.
    Rowley DA; Fitch FW; Axelrad MA; Pierce CW
    Immunology; 1969 Apr; 16(4):549-59. PubMed ID: 4181542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the immunizing capacity of orally administered particulate antigens. I. The efficiency of killed Bordetella pertussis cells.
    Hof H; Finger H; Körner L; Milcke L
    Zentralbl Bakteriol Orig A; 1975; 230(2):210-22. PubMed ID: 167535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of interferon in protection of rabbits against rinderpest virus.
    Fujisaki Y; Ishii S; Watanabe M
    Natl Inst Anim Health Q (Tokyo); 1968; 8(3):122-31. PubMed ID: 5712545
    [No Abstract]   [Full Text] [Related]  

  • 33. Guinea pig anti-insulin serum. Adjuvant effect of H. pertussis vaccine.
    Wright PH; Makulu DR; Posey IJ
    Diabetes; 1968 Aug; 17(8):513-6. PubMed ID: 5668014
    [No Abstract]   [Full Text] [Related]  

  • 34. Intracerebral mouse protection test for petussis vaccine. II. Immunosuppression with cyclophosphamide.
    Blake HE; Wardlaw AC
    Can J Microbiol; 1969 Dec; 15(12):1355-63. PubMed ID: 5369321
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of passive immunization on experimental syphilis in the rabbit.
    Turner TB; Hardy PH; Newman B; Nell EE
    Johns Hopkins Med J; 1973 Nov; 133(5):241-51. PubMed ID: 4586309
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of the immunogenicity and sensitizing properties of pertussis vaccine during oral and parenteral administration].
    Britsina MV; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Oct; (10):51-4. PubMed ID: 4454828
    [No Abstract]   [Full Text] [Related]  

  • 37. Rabies immune globulin (human). Clinical trials and dose determination.
    Loofbourow JC; Cabasso VJ; Roby RE; Anuskiewicz W
    JAMA; 1971 Sep; 217(13):1825-31. PubMed ID: 4105880
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody formation by transferred peritoneal cells and spleen cells of mice. I. Transfer of cells from immunized non-irradiated donors to syngeneic recipients with and without antigen.
    Kornfeld L; Weyzen WW
    Immunology; 1968 Nov; 15(5):751-64. PubMed ID: 5697018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
    Tiru M; Jäätmaa E; Gillenius P; Askelöf P
    Dev Biol Stand; 1985; 61():469-75. PubMed ID: 2872128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immune response of mice to phiX174. The potentiation of B-cell immunity and the suppression of T-cell help by pertussis vaccine.
    Dresser DW; Tao TW
    Immunology; 1975 Mar; 28(3):443-50. PubMed ID: 1079197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.